In small datasets, low BECN1 mRNA expression was associated with triple-negative breast cancer (Cicchini et al., 2014) and with worse prognosis regardless of ER status (Perou et al., 2000, Dong et al., 2013). The gene discussed is BECN1; the disease is triple-negative breast carcinoma.